Axa Us Life Ipo

Axa us life ipo

Subject:

Axa us life ipo

AXA executives held a conference call with securities analysts earlier this week to talk about the company’s plans to buy XL Group, a reinsurer, for $15.3 billion.

Some of the analysts asked Thomas Buberl, AXA’s chief executive officer, and other AXA executives about AXA’s plans to sell stock in AXA Equitable to the public, through an initial public offering (IPO).

That deal raises the possibility that Equitable, which is based in New York, was once one of the dominant players in the U.S.

life insurance market, could get more independence from its corporate parent.

(Related: AXA Talks More About U.S. Life Spinoff)

Here are three of the executives’ answers, based on a transcript of the conference call filed with the U.S.

Axa us life ipo

Securities and Exchange Commission.

  1. When will the IPO really take place?

The company has talked about completing the IPO “in the second quarter” — by June 30.

Gérald Harlin, AXA’s chief financial officer, said the actual timing of the IPO will depend on market conditions.

“We are not in a rush here,” Harlin said. “It could be in two or three years.

Axa us life ipo

The most important point is that we have no constraints.”

2. How much of AXA Equitable’s stock does AXA intend to sell?

About a year ago, AXA executives said they were thinking of selling a minority stake in AXA Equitable.

During this week’s conference call, Buberl said AXA could sell more than a minority stake in AXA Equitable.

AXA expects to sell “a first tranche” in the second quarter of this year, Buberl said.

“Market conditions are good, but the aim is to fully exit the U.S.

life business over time,” Buberl said.

Axa us life ipo

“Obviously, the markets need to be attractive, otherwise we would not do it.”

3. Does AXA need to complete an AXA Equitable deal to pay for XL?

AXA presented a slidedeck slide showing that it intends to use $6 billion from an AXA Equitable IPO to pay for the XL Group.

During the conference call, however, Buberl said the XL deal and the AXA Equitable IPO are “fully separate” transactions.

The IPO “is not a condition for this transaction and combination with the XL Group,” Buberl said.

AXA does, however, need to complete the AXA IPO to shift to a property-casualty insurance focus, from a life insurance focus, Buberl said.

— Read  AXA Aims at U.S.

Benefits Market With Administration Firm Dealon ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on Facebook and Twitter.

Allison Bell, ThinkAdvisor's insurance editor, previously was LifeHealthPro's health insurance editor.

Cryptocurrency is a hassle

She has a bachelor's degree in economics from Washington University in St. Louis and a master's degree in journalism from the Medill School of Journalism at Northwestern University.

Axa us life ipo

She can be reached at [email protected] or on Twitter at @Think_Allison.

More from this author